PACTR202202477162480招募中4 期
Efficacy and safety of RivaroXaban and DAbigatran versus AcenocouMarol in Cerebral Venous Thrombosis (EXAMinCVT)
Hasan II University Hospital of Fez0 个研究点目标入组 60 人开始时间: 2019年2月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •1. Informed consent written in accordance with the rules of good clinical practice and laws in force in the country.
- •2. Confirmed diagnosis of venous or cerebral thrombosis (DVT), with or without intracranial hemorrhage (CT scan injected or brain MRI)
- •3. Curative dose anticoagulant (LMWH) therapy that has been administered from confirmation of diagnosis to randomization;
- •4. Eligibility for oral anticoagulant therapy.
排除标准
- •1. Cerebral venous thrombosis (CVT) associated with central nervous system infection or head trauma.
- •2. Medical or surgical conditions associated with an increased risk of bleeding
- •3. History of symptomatic nontraumatic intracranial hemorrhage at high risk of recurrence
- •4. Treatment with an antithrombotic regimen for an indication other than CVT and requiring continuation of this treatment for the initial diagnosis without modification of the treatment regimen
- •5. Severe renal insufficiency
- •6. Active hepatopathy
- •7. Pregnancy ongoing or planned during the clinical trial
- •8. Any contraindications to VKA or NOAC.
研究者
相似试验
已完成
4 期
A comparison of Dabigatran, Enoxaparin and Rivaroxaban for venous thromboembolism prophylaxisCondition 1: Deep vein thromboembolism. Condition 2: Malignant neoplasm of lower respiratory tract.Acute embolism and thrombosis of deep veins of lower extremityMalignant neoplasm of lower respiratory tract, part unspecifiedI82.4C39.9IRCT20200407046984N1Semnan University of Medical Sciences57
招募中
3 期
Efficacy and safety of rivaroxaban and subcutaneous enoxaparin after spinal surgeryIntravenous thromboembolism.Thromboembolism in the puerperiumO88.23IRCT20211109053014N1Esfahan University of Medical Sciences200
招募中
2 期
Efficiency of rivaroxaban and enoxaparin in the prevention of venous thromboembolic eventsSpinal fusion.Osseous stenosis of neural canalM99.3IRCT20120527009878N16Tabriz University of Medical Sciences60
招募中
2 期
Evaluating the efficacy and safety of rivaroxaban comparing to warfarin in patients with chronic thromboembolic pulmonary hypertension (CTEPH) following endartrectomy surgeryChronic Thrombo Embolic Pulmonary Hypertension(CTEPH).Chronic Thromboembolic Pulmonary Hypertension.I27. 24IRCT20151227025726N22Shahid Beheshti University of Medical Sciences96
进行中（未招募）
不适用
dabigatran and rivaroxaban: prediction of anticoagulant effectEUCTR2012-002263-96-NLMUMC